OTHER CORRESPONDENCE
Novartis Gene Therapies, Inc.FDA OTHER_CORRESPONDENCE - Novartis Gene Therapies, Inc. - August 02, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This OTHER CORRESPONDENCE record concerns Novartis Gene Therapies, Inc., with an inspection on August 2, 2019, issued by the Office of Biological Product Operations, covering biologics.
Open in Dashboard
ID · e848efbe-98af-4b81-a414-7d8ed0d1aa0e
Violation Codes1
21 CFR 210
Full citation text and observation details available on the Dashboard.